MEMPHIS, TN (January 5, 2016) – PMC Biogenix, a wholly owned subsidiary of PMC Group, announced plans to invest in the expansion of its manufacturing capacity for fatty amide slip agents at its production facility in Gyeongju, South Korea. The project will increase PMC’s manufacturing capacity at the site by 30% and will be operational during the first half of 2016. PMC’s operates a global, vertically integrated manufacturing platform for slip agents including two world scale manufacturing sites in Memphis Tennessee and Gyeongju, South Korea, integrated fatty acid manufacturing, and regional distribution centers to serve the global polyolefins industry.
“This investment underscores our position as an industry leader committed to maintaining world class service and security of supply to our global customer base.” said Dr. William Hayes, Vice President and General Manager, about PMC Biogenix’ latest investment. “This project provides our customer base with the confidence that we are prepared to grow with both announced and anticipated global polyolefin capacity increases.